{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:54:49Z","timestamp":1792212889407,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.colsurfb.2013.01.041","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T21:20:25Z","timestamp":1359494425000},"page":"224-233","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B\u2013miltefosine-loaded nanocochleates"],"prefix":"10.1016","volume":"106","author":[{"given":"T.T.H.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saint-Pierre-Chazalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2013.01.041_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis: public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(00)90055-5","article-title":"Visceral leishmaniasis control: a public health perspective","volume":"94","author":"Boelaert","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1007-4376(09)60032-0","article-title":"A review of Leishmaniasis in Eastern Africa","volume":"23","author":"Ngure","year":"2009","journal-title":"J. Nanjing Med. Univ."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"Visceral leishmaniasis in patients infected with the human immunodeficiency virus","volume":"16","author":"Laguna","year":"1997","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study","volume":"80","author":"Pintado","year":"2001","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0045","first-page":"1658","article-title":"Visceral leishmaniasis in HIV infection. A totally opportunistic infection","volume":"21","author":"Cabie","year":"1992","journal-title":"Presse Med."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0050","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"vol. 61","author":"Alvar","year":"2006"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0035-9203(01)90160-9","article-title":"Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India","volume":"95","author":"Thakur","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0065","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0075","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","article-title":"Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis","volume":"94","author":"Gupta","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0085","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0035-9203(00)90130-5","article-title":"A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis","volume":"94","author":"Thakur","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0090","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1128\/AAC.00837-06","article-title":"Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro","volume":"50","author":"M\u00e9nez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1406.019","volume":"1111","author":"Johnson","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/106002807801200906","article-title":"pKa values of medicinal compounds in pharmacy practice","author":"Newton","year":"1978","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0105","first-page":"301","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"2","author":"Barratt","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/chir.530060811","article-title":"Circular dichroism studies of the self-association of amphotericin B","volume":"6","author":"Brittain","year":"1994","journal-title":"Chirality"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0005-2736(88)90519-6","article-title":"Amphotericin B-sterol complex formation and competition with egg phosphatidylcholine: a monolayer study","volume":"944","author":"Saint-Pierre Chazalet","year":"1988","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-4157(86)90002-X","article-title":"How do the polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0125","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1021\/bi00237a011","article-title":"One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium","volume":"30","author":"Bolard","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0130","first-page":"105","article-title":"Biological activity of polyene antibiotics","volume":"vol. 14","author":"Hammond","year":"1977"},{"issue":"Suppl. 1","key":"10.1016\/j.colsurfb.2013.01.041_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","article-title":"Amphotericin B: spectrum and resistance","volume":"49","author":"Ellis","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/08982109309150727","article-title":"How does amphotericin B work? Studies on model membrane systems","volume":"3","author":"Hartsel","year":"1993","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0006-291X(88)80305-X","article-title":"The polyene antibiotic amphotericin B inhibits the Na+\/K+ pump of human erythrocytes","volume":"157","author":"Vertut-Doi","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02427375","article-title":"Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media","volume":"18","author":"Mazerski","year":"1990","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0155","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.36.11.2518","article-title":"Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes","volume":"36","author":"Legrand","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-4165(82)90300-2","article-title":"Self-association of some polyene macrolide antibiotics in aqueous media","volume":"719","author":"Mazerski","year":"1982","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Gen. Subj."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/08982109309150728","article-title":"Mechanism of action of amphotericin B at the cellular level. Its modulation by delivery systems","volume":"3","author":"Bolard","year":"1993","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/infdis\/165.2.337","article-title":"Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture","volume":"165","author":"Joly","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(69)90067-9","article-title":"Nephrotoxic effects of amphotericin B, including renal tubular acidosis","volume":"46","author":"Douglas","year":"1969","journal-title":"Am. J. Med."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0248-8663(00)00304-0","article-title":"Nouvelles formes lipidiques de l\u2019Amphotericine B. Revue de la litt\u00e9rature","volume":"22","author":"Andr\u00e8s","year":"2001","journal-title":"Rev. M\u00e9d. Int."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mycmed.2005.06.005","article-title":"Lipid formulations of amphotericin B: where are we today?","volume":"15","author":"Antoniadou","year":"2005","journal-title":"J. Med. Mycol."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/AAC.34.3.381","article-title":"Amphotericin B: delivery systems","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0165-6147(96)01012-7","article-title":"Amphotericin B: new life for an old drug","volume":"17","author":"Hartsel","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0035-9203(00)90277-3","article-title":"Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis","volume":"94","author":"Sundar","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0940-2993(00)80115-3","article-title":"Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study","volume":"52","author":"Souza","year":"2000","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0210","doi-asserted-by":"crossref","unstructured":"J.D. Berman, G. Ksionski, W.L. Chapman, V.B. Waits, W.L. Hanson, Activity of Amphotericin B Cholesterol Dispersion (amphocil) in Experimental Visceral Leishmaniasis, American Society for Microbiology, Washington, DC, ETATS-UNIS, 1992.","DOI":"10.1128\/AAC.36.9.1978"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0215","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","article-title":"The pharmacology of leishmaniasis","volume":"30","author":"Bala\u00f1a-Fouce","year":"1998","journal-title":"Gen. Pharmacol.: Vasc. Syst."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0220","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0140-6736(91)91708-3","article-title":"Liposomal amphotericin B in drug-resistant visceral leishmaniasis","volume":"337","author":"Davidson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0225","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0230","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone\u00ae","volume":"26","author":"Italia","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0924-8579(00)00341-1","article-title":"Lipid-based amphotericin B: a review of the last 10 years of use","volume":"17","author":"Hann","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.colsurfb.2013.01.041_bib0240","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0245","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0250","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine interaction with lipid monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","article-title":"Ether\u2013lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether\u2013lipid analogues in Leishmania","volume":"111","author":"Lux","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0260","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0005-2736(75)90299-0","article-title":"Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles","volume":"394","author":"Papahadjopoulos","year":"1975","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1978.tb22013.x","article-title":"Calcium-induced lipid phase transition and membrane fusion","volume":"308","author":"Papahadjopoulos","year":"1978","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0280","series-title":"Hydrogel-isolated Cochleate Formulations, Process of Preparation and their Use for the Delivery of Biologically Relevant Molecules","author":"Zarif","year":"2003"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0285","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.44.6.1463-1469.2000","article-title":"Antifungal activity of amphotericin B cochleates against candida albicans infection in a mouse model","volume":"44","author":"Zarif","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0290","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S0074-02762011000200022","article-title":"In vitro activity of amphotericin B cochleates against Leishmania chagasi","volume":"106","author":"Sesana","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0295","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0076-6879(05)91018-5","article-title":"Drug delivery by lipid cochleates","volume":"391","author":"Zarif","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0300","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/jcis.2000.7310","article-title":"Desorption of amphotericin B from mixed monolayers with cholesterol at the air\/water interface","volume":"234","author":"Rey-G\u00f3mez-Serranillos","year":"2001","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0305","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2006.04.059","article-title":"The influence of subphase temperature on miltefosine-cholesterol mixed monolayers","volume":"301","author":"Mi\u00f1ones","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0310","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1039\/B314439A","article-title":"Study of the\u2014a isotherms of miltefosine monolayers spread at the air\/water interface","volume":"6","author":"Rey Gomez-Serranillos","year":"2004","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0315","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1021\/la0489920","article-title":"Stabilization of phospholipid multilayers at the air\u2013water interface by compression beyond the collapse: a BAM, PM-IRRAS, and molecular dynamics study","volume":"20","author":"Saccani","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-3084(71)90030-2","article-title":"Behavior of specific natural lecithins and cholesterol at the air\u2013water-interface","volume":"7","author":"Ghosh","year":"1971","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.colsurfb.2004.06.007","article-title":"Interactions between phosphatidylcholines and cholesterol in monolayers at the air\/water interface","volume":"37","author":"Dynarowicz-\u0141\u0105tka","year":"2004","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcis.2008.02.051","article-title":"Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol\/DPPC mixed monolayers","volume":"322","author":"Chang","year":"2008","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0335","doi-asserted-by":"crossref","DOI":"10.1021\/jp902748s","article-title":"The interaction energies of cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine in spread mixed monolayers at the air\u2013water interface","volume":"113","author":"Savva","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0340","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0927-7765(02)00220-5","article-title":"Interactions of amphotericin B with saturated and unsaturated phosphatidylcholines at the air\/water interface","volume":"29","author":"Mi\u00f1ones","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0005-2736(02)00581-3","article-title":"Comparative molecular dynamics simulations of amphotericin B-cholesterol\/ergosterol membrane channels","volume":"1567","author":"Baginski","year":"2002","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0927-7765(02)00099-1","article-title":"Study of penetration of amphotericin B into cholesterol or ergosterol containing dipalmitoyl phosphatidylcholine Langmuir monolayers","volume":"27","author":"Dynarowicz-\u0141atka","year":"2003","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0355","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-2736(98)00137-0","article-title":"Molecular organisation of amphotericin B at the air\u2013water interface in the presence of sterols: a monolayer study","volume":"1375","author":"Seoane","year":"1998","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.colsurfb.2013.01.041_bib0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2006.04.059","article-title":"The influence of subphase temperature on miltefosine-cholesterol mixed monolayers","volume":"301","author":"Mi\u00f1ones","year":"2006","journal-title":"J. Colloid Interface Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776513000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776513000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:02:51Z","timestamp":1562619771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776513000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":72,"alternative-id":["S0927776513000635"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2013.01.041","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}